K844546

Substantially Equivalent

CYSTINE TRYPTIC AGAR W/SUCROSE

Applicant: bioMerieux, Inc.
Product code: JSF
Advisory panel: Microbiology
Date received: 1984-11-21
Decision date: 1985-01-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Addison, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.